
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
1 Department of Medicine and the Rebecca and John Moores Cancer Center, University of California at San Diego, La Jolla, California; and 2 Department of Metabolic and Endocrine Diseases, University Medical Center Utrecht, The Netherlands
Purpose: Cisplatin (DDP)-resistant cells commonly exhibit reduced drug accumulation. Previous studies have shown that the major copper (Cu) influx transporter CTR1 controls the uptake of DDP in yeast and mammalian cells. The goal of this study was to examine the effect of Cu and DDP on the level and subcellular localization of hCTR1 protein in human ovarian carcinoma cells.
Experimental Design: Cultured human ovarian carcinoma A2780 cells were exposed to DDP and Cu, and the effect on hCTR1 was determined using Western blot analysis and confocal digital deconvolution microscopy.
Results: Loss of hCTR1 was triggered by DDP exposure in a concentration and time-dependent manner. Exposure to 0.5 µmol/L DDP for 5 minutes reduced hCTR1 levels and exposure to DDP concentrations
2 µmol/L caused almost complete disappearance. The loss of hCTR1 was observed within 1 minute of the start of exposure to 2 µmol/L DDP. Treatment of cells with 100 µmol/L Cu for 5 minutes produced a smaller effect. Pretreatment of cells with 2 µmol/L DDP for 5 minutes resulted in a 50% decrease in 64Cu uptake, demonstrating that the DDP-induced loss of hCTR1 detected by Western blot analysis and imaging was functionally significant.
Conclusions: DDP down-regulated the amount of its major influx transporter in cultured human ovarian carcinoma cells in a concentration- and time-dependent manner. The effect was observed at DDP concentrations within the range found in the plasma of patients being treated with DDP, and it occurred very quickly relative to the half-life of the drug.
This article has been cited by other articles:
![]() |
D. J. Stewart, J.-P. Issa, R. Kurzrock, M. I. Nunez, J. Jelinek, D. Hong, Y. Oki, Z. Guo, S. Gupta, and I. I. Wistuba Decitabine Effect on Tumor Global DNA Methylation and Other Parameters in a Phase I Trial in Refractory Solid Tumors and Lymphomas Clin. Cancer Res., June 1, 2009; 15(11): 3881 - 3888. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pabla, R. F. Murphy, K. Liu, and Z. Dong The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity Am J Physiol Renal Physiol, March 1, 2009; 296(3): F505 - F511. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Jandial, S. Farshchi-Heydari, C. A. Larson, G. I. Elliott, W. J. Wrasidlo, and S. B. Howell Enhanced Delivery of Cisplatin to Intraperitoneal Ovarian Carcinomas Mediated by the Effects of Bortezomib on the Human Copper Transporter 1 Clin. Cancer Res., January 15, 2009; 15(2): 553 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, J. You, K. G. Bemis, T. J. Tegeler, and D. P. G. Brown Label-free mass spectrometry-based protein quantification technologies in proteomic analysis Brief Funct Genomic Proteomic, September 1, 2008; 7(5): 329 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sinani, D. J. Adle, H. Kim, and J. Lee Distinct Mechanisms for Ctr1-mediated Copper and Cisplatin Transport J. Biol. Chem., September 14, 2007; 282(37): 26775 - 26785. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Holzer and S. B. Howell The Internalization and Degradation of Human Copper Transporter 1 following Cisplatin Exposure. Cancer Res., November 15, 2006; 66(22): 10944 - 10952. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Holzer, N. M. Varki, Q. T. Le, M. A. Gibson, P. Naredi, and S. B. Howell Expression of the Human Copper Influx Transporter 1 in Normal and Malignant Human Tissues J. Histochem. Cytochem., September 1, 2006; 54(9): 1041 - 1049. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |